Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2003
12/10/2003EP1368045A1 Process for obtention of decoctions of vitis labrusca and vitis vinifera skins
12/10/2003EP1368041A1 Amphotericin b aqueous composition
12/10/2003EP1368040A2 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
12/10/2003EP1368038A1 Methods for the administration of amifostine and related compounds
12/10/2003EP1368019A1 Esmolol formulation
12/10/2003EP1368016A1 Parenteral dosage forms comprising a suspension of tramadol salt and diclofenac salt
12/10/2003EP1368008A1 Transdermal therapeutic system for the administration of partial dopamine-d2 agonists
12/10/2003EP1368007A1 Coating and binding agent for pharmaceutical formulations with improved storage stability
12/10/2003EP1368006A1 Novel modified released formulation
12/10/2003EP1368005A2 Chronotherapeutic dosage forms
12/10/2003EP1368004A2 Mucoadhesive dispersible pharmaceutical preparation for active-agent dosing in veterinary and human medicine
12/10/2003EP1368003A1 Methods and compositions for reducing the taste of pharmaceutically active agents
12/10/2003EP1368001A2 Pharmaceutical formulation comprising bicalutamide
12/10/2003EP1368000A2 Chronotherapeutic dosage forms containing glucocorticosteroid
12/10/2003EP1367999A2 Water soluble and palatable complexes
12/10/2003EP1367997A1 Injectable water-in-oil emulsions
12/10/2003EP1367996A1 Sustained-release suspension of ceftiofur hydrochloride
12/10/2003EP1367995A1 Compositions and methods for enhancing drug delivery across and into epithelial tissues
12/10/2003EP1367994A2 Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors
12/10/2003EP1367982A2 Hair follicle neogenesis by injection of follicle progenitor cells
12/10/2003EP1367981A2 Pearlescent agent
12/10/2003EP1367980A2 Methods of preventing ventilator associated pneumonia by oral administration of antimicrobial ib-367 peptides
12/10/2003EP1367899A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/10/2003EP1276466B1 Directly compressed solid dosage particles
12/10/2003EP1154775B1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol
12/10/2003EP1144420B1 Sulfated phosphatidylinositols, their preparation and use
12/10/2003EP1124582B1 Preservative system for topically administrable pharmaceutical compositions
12/10/2003EP1066058B1 Immunotoxin cocktails for the treatment of immune related diseases
12/10/2003EP0889736B1 Iscom or iscom-matrix comprising a mucus targetting substance and an antigen
12/10/2003EP0883400B1 Delivery system for localized administration of medicaments to the upper respiratory tract
12/10/2003EP0862452B1 Stabilizing formulation for ngf
12/10/2003EP0833666B1 Cytomodulating conjugates of members of specific binding pairs
12/10/2003EP0781125B1 Enteric film coating compositions, method of coating therewith, and coated forms
12/10/2003CN1461344A Multivalent target binding protein
12/10/2003CN1461321A Lactic acid polymer and process for producing the same
12/10/2003CN1461218A Therapeutic combination of amlodipine and benazepril
12/10/2003CN1461214A Compositions for improving skin environment and clothes thereof
12/10/2003CN1461212A Hydrogel-driven drug dosage form
12/10/2003CN1461211A Microparticles for pulmonary administation
12/10/2003CN1461210A Preparation of vitamin emulsions and concentrates thereof
12/10/2003CN1461207A Vaginal delivery of bisphosphonates
12/10/2003CN1461188A Material for inproving living environment, and building material, laying material and spraying agent using the same
12/10/2003CN1460486A Propolis honey sweets and preparation process
12/10/2003CN1460478A Huangyangning slow-releasing preparation
12/10/2003CN1460476A Apomorphine sublingual dripping pill preparation with adjustable medicine-releasing rate
12/10/2003CN1460471A Fenofibrate soft capsule and its preparation method
12/10/2003CN1460470A Dichlofenac sodium slow-releasing preparation and its preparation method
12/10/2003CN1460469A Preparation method of aspirin microsphere
12/10/2003CN1460468A Improved preparation method of high-molecular microsphere embedding protein medicine and vaccine
12/10/2003CN1460467A Adriamycin liposome hydrochloride for injection
12/10/2003CN1130374C Synthetic peptide analogs of lung surfactant protein SP-C
12/10/2003CN1130310C Improved method for preparing low-concentration polyaluminosilicate microgels
12/10/2003CN1130227C Viral agent associated with mystery swine disease
12/10/2003CN1130224C Low sugar content, stabilized, albumin-free recombinant coagulation factor preparation
12/10/2003CN1130223C Pharmaceutical formulation containing growth hormone, amino acid and non-ionic detergent
12/10/2003CN1130203C Injectable formulations of avermectins and milbemycins
12/10/2003CN1130197C Implanted slow-releasing antiseptic preparation and its preparing method
12/10/2003CN1130196C Preparation and method of stabilizing biological matericals by non-freezing drying method
12/10/2003CN1130195C Nanoemulsion based on ethoxylated fatty ether or ethoxylated fatty ester, and use thereof
12/10/2003CN1130171C Stretchable hood utensil containing stretchable adhesive matrix at least in moisture state
12/10/2003CN1130123C Low PH acidic composition
12/09/2003US6660810 Non cross-linked block polyetherester, preparation and uses
12/09/2003US6660776 For use during dental/medical procedures to protect sensitive mouth tissue from latex glove; flavored to prevent unpleasant aftertaste associated with petrolatum
12/09/2003US6660768 Parasiticidal compositions and methods of use
12/09/2003US6660743 Improved stability
12/09/2003US6660729 Particle-forming compositions containing fused pyrrolocarbazoles
12/09/2003US6660525 Therapeutic liposome composition and method
12/09/2003US6660468 Vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction
12/09/2003US6660382 Process for manufacturing coated granules with masked taste and immediate release of the active principle
12/09/2003US6660302 For pharmaceuticals and confectionaries; gum acacia, hydroxypropyl methylcellulose, propylene glycol plasticizer
12/09/2003US6660301 Injectable microspheres for dermal augmentation and tissue bulking
12/09/2003US6660299 Treating a bacterial infection in a human by administering a specified high dosage of amoxycillin over given time
12/09/2003US6660298 Acidulant and a water dispersible polymer to solubilize sufficient paroxetine hydrochloride
12/09/2003US6660296 Neutral granular support coated with an active layer comprising: Diltiazem or a salt, a surfactant, and a binder, and a layer which ensures sustained release of the active principle
12/09/2003US6660293 Carotenoids; vitamins E, D, & C; thiamine; riboflavin; niacin; folic acid; pyridoxine; biotin; pantothenic acid; cobalamin; magnesium; manganese; zinc; selenium; chromium; copper; alpha lipoic acid; and lutein; added iron free
12/09/2003US6660286 Emulsion vehicle for poorly soluble drugs
12/09/2003US6660279 Stability for injection solutions
12/09/2003US6660278 Fatty acid ester of diglycerol as a carrier highly efficient in solubilizing or dispersing biologically active materials
12/09/2003US6660267 Prevention and treatment of sepsis
12/09/2003US6660264 Treatment of intracellular infection
12/09/2003US6660255 Inhibition of gene transcription by polyamide DNA-binding ligands
12/09/2003US6660252 Low emulsifier multiple emulsions
12/09/2003US6660251 Galenic formulation containing biotin
12/09/2003US6660249 Inhalable dry powder aztreonam for treatment and prevention of pulmonary bacterial infections
12/09/2003US6660248 Water solubility; medical diagnosis
12/09/2003US6660247 Multiple stimulus reversible hydrogels
12/09/2003US6660192 Molded waveguides
12/09/2003US6659985 Method to use transdermal administration of androgens to the adnexa of the eye
12/09/2003CA2376833C Oxidatively stable, long-chain ethyl ester emollients
12/09/2003CA2306103C Novel once-a-day controlled release sulfonylurea formulation
12/09/2003CA2301649C Burn treatment composition
12/09/2003CA2227298C Paroxetine controlled release compositions
12/09/2003CA2171462C Compounds for the prevention and treatment of helminth infections
12/09/2003CA2106492C Herpes simplex vaccine comprising hsv glycoprotein gd and 3 deacylated monophosphoryl lipid a
12/04/2003WO2003100081A2 Biologically active maleamic acid derivatives with labile amide bonds
12/04/2003WO2003100042A1 Method for assembling sub units into capsoides
12/04/2003WO2003100033A2 ANTI-αvβ6 ANTIBODIES
12/04/2003WO2003099992A2 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003WO2003099991A2 Glp-1 gene delivery for the treatment of type 2 diabetes
12/04/2003WO2003099830A2 Cardiolipin compositions, methods of preparation and use